CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
120 hedge funds and large institutions have $290M invested in Concert Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 26 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
27% less capital invested
Capital invested by funds: $399M → $290M (-$110M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
120
Holding in Top 10
–
Calls
$462K
Puts
$462K
Top Buyers
| 1 | +$3.83M | |
| 2 | +$3.46M | |
| 3 | +$2.08M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.93M |
| 5 |
Renaissance Technologies
New York
|
+$1.89M |
Top Sellers
| 1 | -$8.02M | |
| 2 | -$4.06M | |
| 3 | -$2.85M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$2.63M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2M |